Sign in to view content

Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

Jennifer I. Lim, MD, FARVO, FASRS

Video
Published 2022

Related

Correlation Of Ganglion Cell Layer Damage And Diabetic Macular Ischemia Using OCT Angiography and Their Relationship With Visual Acuity in Diabetes
Dilraj S Grewal, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Updates from the Field
2021
Photobiomodulation for DME With Good VA: DRCRnet Protocol AE
Judy E. Kim, MD, FASRS
Updates from the Field
2021

Category: Diabetic Retinopathy

See more